SCHEMBL972981

SCHEMBL972981

Cc1ccc(CNS(=O)(=O)c2ccc(-c3csc(C)n3)cc2C)o1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.52
MAPT P10636 3/20 0.42
HPGD P15428 3/20 0.41
HTT P42858 2/20 0.41
SMN1; SMN2 Q16637 3/20 0.40
PRMT6 Q96LA8 1/20 0.40
TP53 P04637 1/20 0.39
MEN1 O00255 1/20 0.39
KMT2A Q03164 1/20 0.39
KDM4E B2RXH2 1/20 0.39
POLB P06746 1/20 0.39
GAA P10253 1/20 0.39
RECQL P46063 1/20 0.39
ESR2 Q92731 1/20 0.39
PTGES2 Q9H7Z7 1/20 0.39
L3MBTL1 Q9Y468 2/20 0.39
GFER P55789 1/20 0.39
NPC1 O15118 1/20 0.39
RAB9A P51151 1/20 0.39
HSD17B10 Q99714 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21183366 0.72 BRD4 (0.53) ALDH1A1MAPTHPGDHTTSMN1; SMN2
SCHEMBL972405 0.67 KMT2A (0.59) MAPTTP53MEN1KMT2ANPC1
SCHEMBL1764528 0.66 GAA (0.64) ALDH1A1MAPTHPGDHTTSMN1; SMN2
SCHEMBL972519 0.65 TP53 (0.62) MAPTTP53MEN1KMT2APOLB
SCHEMBL972512 0.64 TP53 (0.63) MAPTTP53KMT2APOLB
SCHEMBL21183371 0.64 MAPT (0.66) ALDH1A1MAPTHPGDHTTMEN1
SCHEMBL17000511 0.63 MAPT (0.52) ALDH1A1MAPTHPGDHTTSMN1; SMN2
SCHEMBL12169323 0.63 KMT2A (0.57) ALDH1A1MAPTHTTSMN1; SMN2MEN1
SCHEMBL21230568 0.62 GAA (0.53) ALDH1A1MAPTHPGDHTTSMN1; SMN2
SCHEMBL9435249 0.62 MAPT (0.63) ALDH1A1MAPTHPGDHTTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110015065-A1 Substituted Sulfonic Acid Amide Compounds BASF SE (DE) 2011-01-20 US claimed
EP-2252590-A1 SUBSTITUTED SULFONIC ACID AMIDE COMPOUNDS BASF SE (DE) 2010-11-24 EP claimed
WO-2009101082-A1 SUBSTITUTED SULFONIC ACID AMIDE COMPOUNDS BASF SE (DE) 2009-08-20 WO claimed
US-20110015065-A1 Substituted Sulfonic Acid Amide Compounds BASF SE (DE) 2011-01-20 US disclosed
EP-2252590-A1 SUBSTITUTED SULFONIC ACID AMIDE COMPOUNDS BASF SE (DE) 2010-11-24 EP disclosed
WO-2009101082-A1 SUBSTITUTED SULFONIC ACID AMIDE COMPOUNDS BASF SE (DE) 2009-08-20 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110015065-A1 Substituted Sulfonic Acid Amide Compounds STS, NAPA, NAAA ALDH1A1 2768/4885MAPT 3640/4885HPGD 451/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.